Antineoplaston therapy effect on heart rhythm in brainstem glioma
Part of Brain & nervous system, Cancer clinical trials.
This study checks whether the experimental antineoplaston treatment affects the heart's electrical activity in people with a specific type of brain tumor called diffuse intrinsic brainstem glioma. It aims to ensure the treatment is safe for your heart, which is important for overall health during therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be enrolled in another study called BRI-BT-52, which tests antineoplaston therapy for your brain tumor.
- You must have a type of brain tumor called diffuse intrinsic brainstem glioma.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding antineoplaston therapy (a substance that may slow cancer cell growth) to standard radiation helps people with a type of brain tumor called diffuse intrinsic pontine glioma (DIPG). It aims to see if the combination improves outcomes compared to radiation alone.
This study tests a new way to plan and deliver radiation therapy for glioblastoma (an aggressive brain tumor) using special MRI scans to target cancer cells more precisely. The goal is to improve treatment effectiveness while reducing harm to healthy brain tissue.
This trial tests giving a precise dose of radiation directly to the tumor area during surgery for newly diagnosed glioblastoma. The goal is to destroy remaining tumor cells immediately after removal, which may improve outcomes.
This trial tests a special form of radiation therapy for older or frail adults with a type of brain tumor called glioma. The radiation is placed directly in the area where the tumor was removed during surgery, which may help prevent the tumor from growing back.
This study tests whether combining brain stimulation with behavioral therapy before surgery can help surgeons remove more of a slow-growing brain tumor (low-grade glioma) while protecting movement and speech. It may help patients whose tumor is near the part of the brain that controls movement on one side.
This trial tests whether adding nitroglycerin (a medicine that widens blood vessels) to standard whole-brain radiation helps improve treatment for lung cancer that has spread to the brain. It is for people with a specific gene change (EGFR mutation) in their cancer.
Hear when a new Brain Stem Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.